Outcome Prediction for Estrogen Receptor–Positive Breast Cancer Based on Postneoadjuvant Endocrine Therapy Tumor Characteristics

BACKGROUND: Understanding how tumor response is related to relapse risk would help clinicians make decisions about additional treatment options for patients who have received neoadjuvant endocrine treatment for estrogen receptor–positive (ER+) breast cancer. METHODS: Tumors from 228 postmenopausal w...

Descripción completa

Detalles Bibliográficos
Autores principales: Ellis, Matthew J., Tao, Yu, Luo, Jingqin, A'Hern, Roger, Evans, Dean B., Bhatnagar, Ajay S., Chaudri Ross, Hilary A., von Kameke, Alexander, Miller, William R., Smith, Ian, Eiermann, Wolfgang, Dowsett, Mitch
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2008
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2556704/
https://www.ncbi.nlm.nih.gov/pubmed/18812550
http://dx.doi.org/10.1093/jnci/djn309

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2556704/
https://www.ncbi.nlm.nih.gov/pubmed/18812550
http://dx.doi.org/10.1093/jnci/djn309

Ejemplares similares